UAMS basic/translational scientists transcribe cutting-edge research into new identification, treatment, and prevention of cancer, infectious disease, substance abuse and behavioral problems. Researchers work with the American Heart/Stroke Associations, Centers for Disease Control, Dept. of Defense, Food and Drug Administration, National Institutes of Health, National Science Foundation, and other national/international organizations to better the health of Arkansans.
COVID-19 Research
- Funding
- UAMS Research
- Guidelines
- FAQs
UAMS Research News
-
Research Finds Inflammatory Connection for High Cholesterol, Suggests Possible Combo of Medications
New research at the University of Arkansas for Medical Sciences (UAMS) and the affiliated VA Medical Center suggests a combination of drug therapies – one that already exists and a second that would need to be developed to target a specific inflammatory response – could be effective for managing high LDL-cholesterol and atherosclerosis, and the…
-
UAMS-UA Research Yields Long-lasting Disinfectant Spray for Surfaces
Researchers at UAMS and University of Arkansas, Fayetteville, are developing a long-lasting spray that coats and disinfects surfaces for extended periods, even in heavy use, and is less likely to transmit infectious diseases. The project is one of many at both campuses that uses research funding quickly made available during the COVID-19 pandemic for projects…
-
Findings on DNA Damage Repair Published by UAMS Cancer Researcher
A research team led by cancer researcher Justin Leung, Ph.D., at the University of Arkansas for Medical Sciences (UAMS) has uncovered the role of the protein RNF168 in DNA damage repair and shown how mutations of the protein affect people with a rare genetic condition.